SciTech Development Revenue and Competitors
Estimated Revenue & Valuation
- SciTech Development's estimated annual revenue is currently $2M per year.
- SciTech Development's estimated revenue per employee is $201,000
Employee Data
- SciTech Development has 10 Employees.
- SciTech Development grew their employee count by 25% last year.
SciTech Development's People
| Name | Title | Email/Phone |
|---|
SciTech Development Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $101.3M | 360 | 20% | $10.8M | N/A |
#2 | $7.6M | 38 | -3% | N/A | N/A |
#3 | $6.6M | 33 | 32% | N/A | N/A |
#4 | $2M | 10 | 25% | N/A | N/A |
#5 | $11.9M | 59 | -6% | N/A | N/A |
#6 | $17.7M | 88 | 7% | N/A | N/A |
#7 | $72M | 358 | 7% | N/A | N/A |
#8 | $101M | 359 | 29% | $764.2M | N/A |
#9 | $7.2M | 36 | 6% | N/A | N/A |
#10 | $5.6M | 28 | 4% | N/A | N/A |
What Is SciTech Development?
SciTech Development, Inc.\nA clinical-stage, specialty oncology pharmaceutical company\nRevolutionizing how safe and promising yet challenged drugs can be delivered to kill cancer\nST-001 nanoFenretinide: Lead Drug Candidate in Clinical Trials\nWith innovative science and advanced nanotechnology, SciTech has developed ST-001 nanoFenretinide, a patented new drug with clinical trials in progress for T-cell lymphoma (a form of non-Hodgkin lymphoma). FDA has granted Orphan Drug Designation, allowing 7 years of market exclusivity once approved.\n\nST-001 Clinical Trials Update\n► Confirmed partial response and stable disease observed\n► Preliminary data supports that ST-001 is safe and tolerable at escalating dose\nlevels and has shown efficient delivery of therapeutic doses\n► Trial completion for Phase 1a accelerated is targeted for December 2024\n► Small cell lung cancer trial expected to begin Q2 2025\n► NCI provided additional ~$1M gratis supply of fenretinide to dose 300+ patients, complete Phase 1a/b trials, and expand clinical trials\
keywords:N/A
N/A
Total Funding
10
Number of Employees
$2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Grosse Pointe Farms
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 10 | -55% | N/A |
#2 | $3.6M | 30 | -6% | N/A |
#3 | $7.6M | 56 | -10% | N/A |
#4 | $9.6M | 59 | -23% | N/A |
#5 | $35M | 91 | 8% | N/A |